In prostate cancer, a higher PTTG1 level is an independent sign of poor outcome and relates to p53 changes and higher Ki-67, which means it may help for risk grouping and for choosing stronger treatment when needed. The gene discussed is MKI67; the disease is prostate carcinoma.